Novo Nordisk expects China to approve Wegovy this year
COPENHAGEN (Reuters) – Novo Nordisk said on Thursday it expects Wegovy to be approved for sale in China this year and plans to soon launch the popular weight-loss drug in the largest Asian market with capped volumes. The upcoming launch in China will initially focus on patients paying out-of-pocket for Wegovy, the head of Novo’s …
Novo Nordisk expects China to approve Wegovy this year Read More »










